Rusfertide reduces or eliminates phlebotomy needs in polycythemia vera, improving quality of life and symptom control. The VERIFY trial showed 77% clinical response with rusfertide, compared to 33% in ...

CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for phlebotomy among polycythemia vera patients who had been dependent on it, the ...

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

In this fourth part of a discussion with The American Journal of Managed Care®, Andrew Kuykendall, MD, clinical researcher at Moffitt Cancer Center and VERIFY investigator, speaks to the ...

Background Critically ill patients receive frequent routine and recurring blood tests, some of which are unnecessary. Aim To reduce unnecessary routine phlebotomy in a 30-bed tertiary medical-surgical ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Researchers at IIT Bombay have developed the shock syringe, a painless alternative to traditional needles. This device, powered by high-energy shock w ...

Experience painless treatments with needle-free shock syringes, offering innovative, safe, and efficient drug delivery without the discomfort of traditional needles.

Roche wins Vabysmo prefilled syringe EU approval to intensify Eylea challenge Roche’s Vabysmo is now available in prefilled syringes and vials for three retinal conditions.